Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation.

Blood
Lapo AlinariRobert A Baiocchi

Abstract

Epigenetic events that are essential drivers of lymphocyte transformation remain incompletely characterized. We used models of Epstein-Barr virus (EBV)-induced B-cell transformation to document the relevance of protein arginine methyltransferase 5 (PRMT5) to regulation of epigenetic-repressive marks during lymphomagenesis. EBV(+) lymphomas and transformed cell lines exhibited abundant expression of PRMT5, a type II PRMT enzyme that promotes transcriptional silencing of target genes by methylating arginine residues on histone tails. PRMT5 expression was limited to EBV-transformed cells, not resting or activated B lymphocytes, validating it as an ideal therapeutic target. We developed a first-in-class, small-molecule PRMT5 inhibitor that blocked EBV-driven B-lymphocyte transformation and survival while leaving normal B cells unaffected. Inhibition of PRMT5 led to lost recruitment of a PRMT5/p65/HDAC3-repressive complex on the miR96 promoter, restored miR96 expression, and PRMT5 downregulation. RNA-sequencing and chromatin immunoprecipitation experiments identified several tumor suppressor genes, including the protein tyrosine phosphatase gene PTPROt, which became silenced during EBV-driven B-cell transformation. Enhanced PTPROt e...Continue Reading

References

Dec 5, 1993·Journal of Molecular Biology·A Sali, T L Blundell
Aug 18, 2001·Molecular and Cellular Biology·M G GuentherM A Lazar
Oct 29, 2004·Nature Reviews. Cancer·Lawrence S Young, Alan B Rickinson
Jan 24, 2006·Molecular and Cellular Biology·Xavier Le GuezennecHendrik G Stunnenberg
Aug 22, 2007·Journal of Cellular Physiology·Sharmistha Pal, Saïd Sif
Nov 14, 2007·PLoS Pathogens·Kathy H Y ShairNancy Raab-Traub
Apr 23, 2008·Current Protocols in Protein Science·Narayanan EswarAndrej Sali
Nov 18, 2008·Nature Cell Biology·Martin JanssonNicholas B La Thangue
Jun 17, 2009·Nucleic Acids Research·A ScoumanneX Chen
Nov 16, 2010·Cancer Cell·Srividya BhaskaraScott W Hiebert
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Oct 7, 2011·Trends in Biochemical Sciences·Vrajesh KarkhanisSaïd Sif
Dec 7, 2011·Proceedings of the National Academy of Sciences of the United States of America·Litao SunRui-Ming Xu
Apr 5, 2012·Cell Communication and Signaling : CCS·Niklas EngelsJürgen Wienands
Oct 17, 2012·Proceedings of the National Academy of Sciences of the United States of America·Stephen AntonysamySpencer Emtage
Dec 25, 2012·Biochemical and Biophysical Research Communications·Cheng-Der LiuChih-Wen Peng
Aug 2, 2013·Proceedings of the National Academy of Sciences of the United States of America·Han WeiTao Lu
Feb 3, 2015·Cell Host & Microbe·Hufeng ZhouBo Zhao

❮ Previous
Next ❯

Citations

Jan 21, 2016·Expert Opinion on Investigational Drugs·Hao HuY George Zheng
May 15, 2015·Chemical Reviews·Jakob FuhrmannPaul R Thompson
Dec 22, 2015·ACS Chemical Biology·Jakob Fuhrmann, Paul R Thompson
Oct 10, 2015·Current Hematologic Malignancy Reports·A A GruP Porcu
Sep 20, 2016·The Journal of Clinical Investigation·Yanli JinJingxuan Pan
Dec 13, 2016·International Journal of Cancer. Journal International Du Cancer·Bradley M HaverkosPierluigi Porcu
Feb 24, 2017·Nature Reviews. Cancer·Jake ShorttJames E Bradner
Mar 25, 2017·Chemical Reviews·H Ümit KaniskanJian Jin
Nov 7, 2017·Neuro-oncology·Yeshavanth Kumar Banasavadi-SiddegowdaBalveen Kaur
Jan 15, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lindsay M WebbMireia Guerau-de-Arellano
Oct 28, 2017·Future Medicinal Chemistry·André Richters
May 22, 2018·Expert Opinion on Therapeutic Targets·Emily SmithRobert A Baiocchi
Apr 2, 2019·Chemical & Pharmaceutical Bulletin·Hongrui TaoHua Zhang
Jan 8, 2019·Oncotarget·Harshita ShaileshSaïd Sif
Sep 20, 2017·The Cancer Journal·Michael T McCabeRyan G Kruger
Aug 22, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Marta W SzulikSarah Franklin
Jul 22, 2018·Nature Communications·Antonella ScaglionePatrizia Casaccia
Mar 7, 2019·Nature Reviews. Clinical Oncology·David SermerAnas Younes
Dec 11, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Renato Ferreira de FreitasMatthieu Schapira
Apr 29, 2015·Nature Chemical Biology·Elayne Chan-PenebreKenneth W Duncan
Jun 27, 2019·Cell Cycle·Jiamin JinTao Lu
Mar 30, 2018·Frontiers in Chemistry·Wenchao LuCheng Luo
Jun 20, 2020·Scientific Reports·Ann-Kathrin SchnormeierMax Koeppel

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.